Regenerx Biopharma buy melinda
Start price
01.11.10
/
50%
€0.13
Target price
02.05.11
€0.20
Performance (%)
-17.32%
End price
02.05.11
€0.11
Summary
This prediction ended on 02.05.11 with a price of €0.11. The price of Regenerx Biopharma has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.32%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regenerx Biopharma | - | - | - | - |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% | 64.713% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% | 88.244% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% | 79.311% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% | 69.603% |
Comments by melinda for this prediction
In the thread Regenerx Biopharma diskutieren
Biopharma-
regernerx Biopharma hat die Rechte der NIH, dass das Unternehmen seine Aufmerksamkeit auf ProtectOn und die Reparatur von Gewebe konzentrieren können erworben
(Laufzeit überschritten)


